Pharmacy benefit managers, the drug industry middlemen who have been derided by everyone from community pharmacists to President Trump, have a new chief defender: longtime D.C. lobbyist JC Scott.

Scott, who most recently served as chief advocacy officer and head of external affairs at the medical device lobby, the Advanced Medical Technology Association, announced Thursday he will succeed Mark Merritt as the head of the PBM lobby, the Pharmaceutical Care Management Association, starting Oct 15.

Unlock this article by subscribing to STAT Plus and enjoy your first 30 days free!

GET STARTED

What is it?

STAT Plus is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • Online intelligence briefings
  • Frequent opportunities to engage with veteran beat reporters and industry experts
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.

Leave a Comment

Please enter your name.
Please enter a comment.

  • Well of course they did! I wonder how many more American lives, this will cost. The device industry made sure that physicians, and hospitals could redact the names and registration records, form patient files, in order to hide the number of faulty devices, and protect the industry. This should be evidence of how corrupt the system is, instead it reads like public relations.

Sign up for our Daily Recap newsletter

A roundup of STAT’s top stories of the day in science and medicine

Privacy Policy